FTC sues important pharmacy advantage supervisors above insulin selling prices The company brought motion versus Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the list cost of daily life-saving insulin medicine. Don't skip tomorrow's healthcare field news Let Healthcare Dive's no cost newsletter https://kethek.com/